Bio-Rad Laboratories Inc Class A (BIO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Norman D. Schwartz
Employees:
8,250
1000 ALFRED NOBEL DRIVE, HERCULES, CA 94547
5107247000

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company operates through followings segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. Bio-Rad Laboratories was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Data derived from most recent annual or quarterly report
Market Cap 14.024 Billion Shares Outstanding24.836 Million Avg 30-day Volume 183.161 Thousand
P/E Ratio4.6191 Dividend Yield0.0 EPS131.75
Price to Revenue6.9065 Debt to Equity0.0014 EBITDA4.929 Billion
Price to Book Value1.7795 Operating Margin16.1437 Enterprise Value7.038 Billion
Current Ratio3.388 EPS Growth1.166 Quick Ratio2.234
1 Yr BETA 0.7573 52-week High/Low 832.7 / 547.22 Profit Margin149.5218
Operating Cash Flow Growth25.6457 Altman Z-Score6.0008 Free Cash Flow to Firm 907.374 Million

Are you looking for this stock instead?

View SEC Filings from BIO instead.

View recent insider trading info

Funds Holding BIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

502 total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MAY SIMON EVP, PRESIDENT, LSG

  • Officer
43 2022-01-04 1

WRIGHT DARA EXECUTIVE VICE PRESIDENT

  • Officer
2,399 2021-12-16 2

TUMOLO ANNETTE EXECUTIVE VICE PRESIDENT

  • Officer
13,358 2021-11-11 5

SCHWARTZ STEVEN D

  • 10% Owner
4,424,018 2021-11-09 1

SCHWARTZ NORMAN D CHAIRMAN, PRESIDENT, AND CEO

  • Officer
  • Director
  • 10% Owner
4,496,582 2021-11-09 4

SCHWARTZ ALICE N

  • Director
  • 10% Owner
7,279,479 2021-11-09 1

CROWLEY MICHAEL EVP, GBL COMMERCIAL OPERATIONS

  • Officer
5,073 2021-09-07 4

ERNST TIMOTHY S EVP, GENERAL COUNSEL & SEC

  • Officer
2,153 2021-09-07 5

DASKAL ILAN EVP, CHIEF FINANCIAL OFFICER

  • Officer
9 2021-09-03 4

LAST ANDREW J. EVP, CHIEF OPERATING OFFICER

  • Officer
13,790 2021-09-01 2

RAMALINGAM AJIT SVP, CHIEF ACCOUNTING OFFICER

  • Officer
1,789 2021-09-01 2

HUTTON RONALD W VICE PRESIDENT AND TREASURER

  • Officer
4,688 2020-09-11 0

MAGNI GIOVANNI EVP, CHIEF STRATEGY OFFICER

  • Officer
22,495 2020-09-10 0

STARK JAMES R VP, CORPORATE CONTROLLER

  • Officer
0 2019-11-11 0

HERTIA JOHN EXECUTIVE VICE PRESIDENT

  • Officer
18,980 2019-09-12 0

TSINGOS CHRISTINE A EVP AND CFO

  • Officer
6,683 2018-12-14 0

GOETZ JOHN EVP, CHIEF OPERATING OFFICER

  • Officer
66,473 2017-09-13 0

HALL SHANNON EXECUTIVE VICE PRESIDENT

  • Officer
565 2017-09-13 0

HINCKLEY GREGORY K

  • Director
500 2017-05-26 0

EDWARDS JEFFREY L

  • Director
0 2017-04-25 0

PINKSTON ARNOLD A

  • Director
0 2017-04-25 0

PEI MELINDA LITHERLAND

  • Director
0 2017-04-25 0

SODERBERG SHAWN MARIE EVP, GENERAL COUNSEL, SEC

  • Officer
652 2015-12-14 0

MCCOMB JOEL

  • Director
400 2014-07-23 0

SCHWARTZ DAVID CHAIRMAN OF THE BOARD

  • Officer
  • Director
  • 10% Owner
7,390,891 2011-12-14 0

WADLER SANFORD VP, GENERAL COUNSEL, SECRETARY

  • Officer
11,936 2011-12-14 0

CRUTCHFIELD BRADFORD VICE PRESIDENT

  • Officer
5,811 2011-11-16 0

NEFF DEBORAH J

  • Director
0 2011-10-26 0

BENNETT JAMES

  • Director
80,000 2010-11-19 0

LOVE TED W

  • Director
0 2010-03-24 0

HILLMAN AL

  • Director
15,160 2009-12-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WRIGHT DARA - Officer EXECUTIVE VICE PRESIDENT

2021-12-17 14:21:01 -0500 2021-12-16 M 502 a 1,113 direct -0.3951 4.4924 4.4924 6 -0.3951 2

WRIGHT DARA - Officer EXECUTIVE VICE PRESIDENT

2021-12-17 14:21:01 -0500 2021-12-16 M 502 d 1,507 direct

WRIGHT DARA - Officer EXECUTIVE VICE PRESIDENT

2021-12-17 14:21:01 -0500 2021-12-16 F 221 $734.34 d 892 direct -0.3951 4.4924 4.4924 6 -0.3951 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIO-RAD LABORATORIES-A BIO 2022-01-28 19:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 19:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 18:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 18:15:04 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 17:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 17:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 16:45:04 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 16:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 15:45:04 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 15:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 14:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 14:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 13:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 13:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-28 12:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-27 22:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-27 21:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-27 21:15:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-27 20:45:03 UTC -0.18 0.25 600000
BIO-RAD LABORATORIES-A BIO 2022-01-27 20:15:04 UTC -0.18 0.25 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Master Neutral Fund BIO -2.0 shares, $-1030.92 2020-09-30 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund BIO -161.0 shares, $-93853.34 2020-12-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund BIO -408.0 shares, $-234098.16 2021-01-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund BIO -76.0 shares, $-56692.2 2021-09-30 N-PORT
FundVantage Trust- Gotham Enhanced 500 Plus Fund BIO -7.0 shares, $-5221.65 2021-09-30 N-PORT
FundVantage Trust- Gotham Hedged Core Fund BIO -14.0 shares, $-10443.3 2021-09-30 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund BIO -393.0 shares, $-312309.24 2021-10-31 N-PORT

Elevate your investments